4925 — Haba Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- ¥7bn
- ¥5bn
- ¥12bn
- 85
- 37
- 39
- 56
Annual cashflow statement for Haba Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,928 | 284 | -267 | -549 | -1,843 |
| Depreciation | |||||
| Non-Cash Items | 99.2 | -23.6 | 26.3 | 3.23 | 1,661 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,982 | -395 | 1,247 | 41.7 | -925 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 676 | 535 | 1,714 | 56 | -588 |
| Capital Expenditures | -910 | -882 | -188 | -289 | -433 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -10.3 | -43.4 | -29 | 74.2 | -8.51 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -920 | -925 | -216 | -214 | -442 |
| Financing Cash Flow Items | — | -0.002 | -0.001 | — | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -449 | 825 | -1,513 | -676 | 171 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -694 | 435 | -12.3 | -833 | -859 |